John Dado

Cooley advised Amplify Partners, an early-stage venture capital firm dedicated to technical founders, on the formation of three new funds – Fund 6, Fund 6 Select and Amplify Bio – with a combined $900 million in capital.

Cooley advised Pelion Venture Partners, an early stage venture capital firm based in Salt Lake City, on the raise of its eighth venture fund at $500 million.

Cooley advised Trinity Ventures, an early-stage technology venture capital firm, in connection with the design, implementation and execution of a continuation fund transaction that resulted in the close of Trinity Ventures 2024, with approximately $435 million in total commitments.

Cooley advised Theory Ventures, a venture capital firm focused on early-stage software investments across data, artificial intelligence and Web3, on its $450 million second fund.

Cooley advised Chemistry, an early-stage venture firm that leads investments in standout software companies at the Seed and Series A stages, on its $350 million debut fund, Chemistry Fund 1.